IL113661A0 - Compositions and treatment for multiple sclerosis - Google Patents

Compositions and treatment for multiple sclerosis

Info

Publication number
IL113661A0
IL113661A0 IL11366195A IL11366195A IL113661A0 IL 113661 A0 IL113661 A0 IL 113661A0 IL 11366195 A IL11366195 A IL 11366195A IL 11366195 A IL11366195 A IL 11366195A IL 113661 A0 IL113661 A0 IL 113661A0
Authority
IL
Israel
Prior art keywords
compositions
treatment
multiple sclerosis
sclerosis
Prior art date
Application number
IL11366195A
Other languages
English (en)
Original Assignee
Immulogie Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogie Pharmaceutical Corp filed Critical Immulogie Pharmaceutical Corp
Publication of IL113661A0 publication Critical patent/IL113661A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11366195A 1994-05-10 1995-05-08 Compositions and treatment for multiple sclerosis IL113661A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24124694A 1994-05-10 1994-05-10
US32822494A 1994-10-25 1994-10-25

Publications (1)

Publication Number Publication Date
IL113661A0 true IL113661A0 (en) 1995-08-31

Family

ID=26934122

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11366195A IL113661A0 (en) 1994-05-10 1995-05-08 Compositions and treatment for multiple sclerosis

Country Status (11)

Country Link
EP (1) EP0758902A1 (hu)
JP (1) JPH10500109A (hu)
AU (1) AU2470595A (hu)
CA (1) CA2189990A1 (hu)
CZ (1) CZ329596A3 (hu)
HU (1) HUT76099A (hu)
IL (1) IL113661A0 (hu)
PL (1) PL317197A1 (hu)
SI (1) SI9520059A (hu)
SK (1) SK145896A3 (hu)
WO (1) WO1995030435A2 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4278296A (en) * 1994-10-25 1996-05-15 Immulogic Pharmaceutical Corporation Compositions and treatment for multiple sclerosis
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
CA2250361A1 (en) * 1996-03-28 1997-10-02 Barbara Wallner Myelin oligodendrocyte glycoprotein peptides and uses thereof
WO1998006861A2 (en) * 1996-08-15 1998-02-19 Agrivax Incorporated Delivery of tolerogenic antigens via edible plants or plant-derived products
AUPP823999A0 (en) * 1999-01-20 1999-02-11 University Of Queensland, The A treatment
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
PT1311542E (pt) * 2000-08-21 2008-10-03 Apitope Technology Bristol Ltd Péptidos tolerogénicos
GB0202399D0 (en) * 2002-02-01 2002-03-20 Univ Bristol Peptide
ES2325660T3 (es) 2002-03-27 2009-09-11 Aegera Therapeutics Inc. Oligomeros nucleobasicos de iap no codificantes y usos de los mismos.
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
BG1430U1 (bg) * 2010-06-25 2011-04-29 Иван ИВАНОВ Фармацевтично средство
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133749A1 (en) * 1992-04-09 1993-10-28 Howard L. Weiner Suppression of t-cell proliferation using peptide fragments of myelin basic protein
JPH08500823A (ja) * 1992-08-17 1996-01-30 オートイミューン インク レトロウィルス関連神経疾患のバイスタンダー抑制

Also Published As

Publication number Publication date
PL317197A1 (en) 1997-03-17
WO1995030435A3 (en) 1995-12-07
WO1995030435A2 (en) 1995-11-16
AU2470595A (en) 1995-11-29
SI9520059A (en) 1997-08-31
CZ329596A3 (en) 1997-05-14
HUT76099A (en) 1997-06-30
EP0758902A1 (en) 1997-02-26
JPH10500109A (ja) 1998-01-06
HU9603116D0 (en) 1997-01-28
CA2189990A1 (en) 1995-11-16
SK145896A3 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
IL115891A0 (en) Hemorrhoidial compositions and their use
EG20753A (en) Synergistic composition
GB9208339D0 (en) Treatment composition
GB9415421D0 (en) Cosmetic compositions and processes for manufacture thereof
IL115766A0 (en) Composition and treatment for multiple sclerosis
ZA952356B (en) Skin treatment composition
HUT78017A (hu) Fogápoló készítmény
GB9423952D0 (en) Cleaning compositions and their use
EP0803255A4 (en) DRUG
IL113661A0 (en) Compositions and treatment for multiple sclerosis
ZA9510792B (en) Polymerization compounds and compositions
IL111554A0 (en) Methods and compositions for hair treatment
GB9423234D0 (en) Cleaning compositions and their use
GB9415420D0 (en) Cosmetic compositions and processes for manufacture thereof
IL112564A0 (en) 1-beta-methyl-carbapenems and compositions containing them
EP0835092A4 (en) COMPOSITION AND TREATMENT FOR THE CONTROL OF Baldness
GB9405021D0 (en) Skin treatment composition
ZA948585B (en) Cleaning methods and compositions for produce
GB9404301D0 (en) Stripper compositions and their use
GB9415901D0 (en) Novel compounds and treatment
GB9415900D0 (en) Novel compounds and treatment
GB9525048D0 (en) Composition compound and use
ZA952120B (en) Skin treatment composition
ZA953730B (en) Compositions and treatment for multiple sclerosis
GB9416340D0 (en) Oil treatment and compositions therefor